Michel Gillard
UCB S.A. Pharma Sector
In Vitro Pharmacology
Braine l'Alleud
Belgium
Name/email consistency: high
- Changes in pH differently affect the binding properties of histamine H1 receptor antagonists. Gillard, M., Chatelain, P. Eur. J. Pharmacol. (2006)
- Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Gillard, M., Chatelain, P., Fuks, B. Eur. J. Pharmacol. (2006)
- H1 antagonists: receptor affinity versus selectivity. Gillard, M., Christophe, B., Wels, B., Peck, M., Massingham, R., Chatelain, P. Inflamm. Res. (2003)
- Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain. Gillard, M., Fuks, B., Michel, P., Vertongen, P., Massingham, R., Chatelain, P. Eur. J. Pharmacol. (2003)
- Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). Gillard, M., Van Der Perren, C., Moguilevsky, N., Massingham, R., Chatelain, P. Mol. Pharmacol. (2002)
- Binding characteristics of [3H]levocetirizine to cloned human H1-histamine-receptors expressed in CHO cells. Gillard, M., Van der Perren, C., Massingham, R., Chatelain, P. Inflamm. Res. (2002)
- Major role for the carboxylic function of cetirizine and levocetirizine in their binding characteristics to human H1-histamine-receptors. Gillard, M., Van der Perren, C., Moguilevsky, N., Massingham, R., Chatelain, P. Inflamm. Res. (2002)